Last Updated : April 7, 2025
Details
| Call for patient/clinician input open | 23-Apr-24 |
|---|---|
| Call for patient/clinician input closed | 17-Jun-24 |
| Submission received | 04-Jun-24 |
| Submission accepted | 18-Jun-24 |
| Review initiated | 19-Jun-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 05-Sep-24 |
| Deadline for sponsors comments | 16-Sep-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 10-Oct-24 |
| Expert committee meeting (initial) | 23-Oct-24 |
| Draft recommendation issued to sponsor | 05-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 14-Nov-24 |
| End of feedback period | 28-Nov-24 |
| Final recommendation issued to sponsor and drug plans | 12-Dec-24 |
| Final recommendation posted | 07-Jan-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 03-Jan-25 |
| CDA-AMC review report(s) posted | 07-Apr-25 |